Report Content
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 ECG stress test industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 End-use trends
Chapter 3 ECG Stress Test Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increase in prevalence of cardiovascular disorders
3.2.1.2 Rising awareness for benefits associated with early diagnosis of heart diseases
3.2.1.3 Increasing elderly and obese patient population
3.2.1.4 Surge in number of tests performed by sporting athletes
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of ECG stress testing systems
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Stress test – Conceptual overview
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix
4.4 Vendor matrix analysis
4.5 Strategy dashboard, 2022
Chapter 5 ECG Stress Test Market Size and Forecast, By Product Type (USD Million)
5.1 Key product type trends
5.2 Exercise testing systems
5.3 Stress blood pressure monitors
5.4 Stress ECG
5.5 Pulse oximeters
Chapter 6 ECG Stress Test Market Size and Forecast, By End-use (USD Million)
6.1 Key end-use trends
6.2 Hospitals
6.3 Diagnostic Centers
6.4 Ambulatory Surgical Centers
6.5 Others
Chapter 7 ECG Stress Test Market Size and Forecast, By Region (USD Million)
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Poland
7.3.7 Sweden
7.3.8 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Indonesia
7.4.7 Philippines
7.4.8 Vietnam
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Columbia
7.5.5 Chile
7.5.6 Peru
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Turkey
7.6.5 Israel
7.6.6 Iran
Chapter 8 Company Profiles
8.1 Koninklijke Philips NV
8.2 Becton Dickinson and Co.
8.3 Biosensors International Group Ltd.
8.4 Cardinal Health Inc.
8.5 COSMED Srl
8.6 Fukuda Denshi Co. Ltd.
8.7 General Electric Co.
8.8 Halma Plc
8.9 Hill Rom Holdings Inc.
8.10 MGC Diagnostics Corp.
8.11 Neurosoft
8.12 Nihon Kohden Corp.
8.13 Nonin Medical Inc.
8.14 OSI Systems Inc.
8.15 SCHILLER AG
8.16 Siemens Healthineers AG
8.17 Vyaire Medical Inc.
